Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
5
8
1
0
Neoleukin Therapeutics, Inc.
Share · US64049K2033 · NLTX (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Neoleukin Therapeutics, Inc.
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 58,03 %
Shares Float 1,36 M
Shares Outstanding 2,35 M
Company Profile for Neoleukin Therapeutics, Inc. Share
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
Company Data
Name Neoleukin Therapeutics, Inc.
Company Neoleukin Therapeutics, Inc.
Symbol NLTX
Website
https://www.neoleukin.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US64049K2033
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Donna M. Cochener-Metcalfe
Country United States of America
Currency USD
Employees 0,0 T
Address 188 East Blaine Street, 98102 Seattle
IPO Date 2014-03-07
Stock Splits
| Date | Split |
|---|---|
| 19.12.2023 | 1:4 |
| 25.09.2023 | 1:5 |
| 21.11.2013 | 1:50 |
ID Changes
| Date | From | To |
|---|---|---|
| 12.08.2019 | AQXP | NLTX |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | NLTX |
More Shares
Investors who hold Neoleukin Therapeutics, Inc. also have the following shares in their portfolio:
